Along the same lines, a previous study observed a similar distribution of EGFR mutations among early-stage and metastatic EGFR+ lung cancers (18), which is also consistent with the notion that EGFR alterations represent “early events” during lung carcinogenesis (19). The gene discussed is EGFR; the disease is lung cancer.